If patients were initially started on heparin and then switched to bivalirudin, the length of heparin therapy, hepa- rin dose just prior to transition, justification for switching, and number of AT3 (Thrombate) doses administered were collected. In our practice, AT3 doses are administered at the discretion of the treating physician but typically at a level